Cancer immunotherapy company MabVax Therapeutics and Telik, a clinical stage oncology drug development company have entered into a definitive merger agreement. MabVax is backed by Numoda Capital Innovations, Burrill Capital and RTP Venture Fund.
Apollo funds complete minority investment in Alpine-backed Apex Service Partners
30 October 2026 · 2 mins read
Rainier Partners invests in Texas auto insurance MGA platform Apex
30 October 2026 · 2 mins read
Stonepeak completes carve-out of BMO’s transportation and vendor finance units
30 October 2026 · 2 mins read
Trivest-backed Wheelhouse buys California and Utah garage door firm All Star
30 October 2026 · 1 min read
Water Street and JLL Partners’ Eversana announces acquisition of London’s Estima Scientific
30 October 2026 · 1 min read
DPE’s Mehler Systems to acquire majority stake in Bulgaria’s MARS Armor
30 October 2026 · 1 min read
Speyside Equity buys Midwest steel tubing and building products maker Tapco
29 October 2026 · 2 mins read
